Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07071636
What this trial is testing

Clinical Efficacy of Pegylated Interferon Alpha-2b Combined With Nucleos(t)Ide Analogues in the Treatment of Chronic Hepatitis B Patients

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseChronic Hepatitis B
Shenzhen Third People's Hospital 830
Not applicableStudy completedNCT01474811
What this trial is testing

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

Who this might be right for
Hepatitis C
University of North Carolina, Chapel Hill 13,559
Testing effectiveness (Phase 2)Study completedNCT03781934
What this trial is testing

Evaluate MIV-818 in Patients With Liver Cancer Manifestations

Who this might be right for
Hepatocellular CarcinomaIntrahepatic CholangiocarcinomaLiver Metastases
Medivir 53
Not applicableUnknownNCT04254822
What this trial is testing

HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients

Who this might be right for
Liver CirrhosesVariceal HemorrhageEsophageal Varices
Air Force Military Medical University, China 220
Not applicableStudy completedNCT03847753
What this trial is testing

Exploring the Comorbidity Between Mental Disorders and General Medical Conditions

Who this might be right for
Organic, Including Symptomatic, Mental DisordersSubstance UseSchizophrenia+38 more
University of Aarhus 5,940,299
Testing effectiveness (Phase 2)Looking for participantsNCT07560566
What this trial is testing

SHIELD: Sorafenib Hand-foot Syndrome Inhibition With Pre-Emptive Local Delivery of Topical Indomethacin

Who this might be right for
Hepato Cellular Carcinoma (HCC)Hand Foot Skin Syndrome
National Taiwan University Hospital 39
Large-scale testing (Phase 3)UnknownNCT04667351
What this trial is testing

HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial

Who this might be right for
HepatoCellular Carcinoma
Sun Yat-sen University 400
Not applicableStudy completedNCT02355951
What this trial is testing

Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection

Who this might be right for
Chronic Hepatitis B
Transgene 166
Not applicableUnknownNCT05650151
What this trial is testing

Peri-operative Vitamin D Therapy for Hepatectomy

Who this might be right for
Vitamin D DeficiencyHepatocellular CarcinomaPerioperative Complication
National Taiwan University Hospital 200
Not applicableStudy completedNCT05767229
What this trial is testing

Acute Hemodynamic Response to Carvedilol in Children With Clinically Significant Portal Hypertension.

Who this might be right for
Portal Hypertension
Institute of Liver and Biliary Sciences, India 40
Large-scale testing (Phase 3)Study completedNCT01290731
What this trial is testing

TMC435 in Genotype 1, Hepatitis C-infected Patients Who Relapsed After Previous Interferon (IFN)-Based Therapy

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 49
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07537777
What this trial is testing

Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)First-line Targeted Therapy FailureOligometastatic Hepatocellular Carcinoma+3 more
Nanfang Hospital, Southern Medical University 29
Large-scale testing (Phase 3)Study completedNCT02032901
What this trial is testing

Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 173
Not applicableUnknownNCT01957241
What this trial is testing

PLA for HCC and Esophageal ca Serum

Who this might be right for
Hepatocellular CarcinomaEsophageal Cancer
National Taiwan University Hospital 164
Not applicableUnknownNCT02564666
What this trial is testing

The Effect of Telephone Counseling on the Compliance and Satisfaction for Advanced HCC Patients Receiving Sorafenib

Who this might be right for
Hepatocellular Carcinoma
Asan Medical Center 64
Testing effectiveness (Phase 2)Study completedNCT02138253
What this trial is testing

A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV

Who this might be right for
Liver FibrosisHepatic FibrosisLiver Cirrhosis+1 more
Conatus Pharmaceuticals Inc. 64
Not applicableActive Not RecruitingNCT06905795
What this trial is testing

Screening and Intervention of MASLD in Children

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseChildren
Ningbo No. 1 Hospital 270
Early research (Phase 1)Study completedNCT01288677
What this trial is testing

TMC649128HPC1001 - First In-human Trial to Examine Safety, Tolerability, and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses of TMC649128 in Healthy Volunteers

Who this might be right for
Healthy Volunteer
Tibotec Pharmaceuticals, Ireland 54
Not applicableStudy completedNCT05018741
What this trial is testing

Prognostic Factors After Liver Transplantation

Who this might be right for
Liver DiseasesLiver Transplant; Complications
Changhua Christian Hospital 600
Very early researchStudy completedNCT05250895
What this trial is testing

BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy

Who this might be right for
BCLC Stage a Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma+1 more
Emory University 9
Next Page